Posted by
eletriptan, Relpax

eletriptan, Relpax

What is eletriptan, and how does it work (mechanism of action)? Eletriptan is an oral drug that is used for treating migraine headaches. It is in the “triptan” class of drugs that also includes sumatriptan (Imitrex), zolmitriptan (Zomig), naratriptan (Amerge), rizatriptan (Maxalt), almotriptan (Axert), and frovatriptan (Frova). Migraine headaches are believed to be the result […]

Posted by
New Migraine Drug Might Help When Other Meds Don’t

New Migraine Drug Might Help When Other Meds Don’t

By Amy NortonHealthDay Reporter Latest Migraine News WEDNESDAY, July 10, 2019 (HealthDay News) — A new migraine drug might offer an alternative to people who do not get relief from current medications, a new trial suggests. The drug, called rimegepant, hasn’t yet been approved by the U.S. Food and Drug Administration. But it belongs to […]

Posted by
sumatriptan, Imitrex, Alsuma, Imitrex STATdose System, Sumavel DosePro

sumatriptan, Imitrex, Alsuma, Imitrex STATdose System, Sumavel DosePro

What is sumatriptan? What are the uses for sumatriptan? Sumatriptan is a drug that is used for treating migraine headaches. It belongs to a class of drugs called selective serotonin receptor agonists. Other members of this class include naratriptan (Amerge), zolmitriptan (Zomig), rizatriptan (Maxalt), frovatriptan (Frova), eletriptan (Relpax), and almotriptan (Axert). Migraine headaches are believed […]

Posted by
Money Worries Around Food May Spur Migraines

Money Worries Around Food May Spur Migraines

By Amy NortonHealthDay Reporter Latest Migraine News TUESDAY, June 25, 2019 (HealthDay News) — It’s a link that few might consider, but new research suggests young adults who worry about affording groceries may be more likely to suffer migraines. The study, of nearly 15,000 Americans aged 24 to 32, found that migraines were common among […]

Posted by
Emgality Receives First FDA Approval for Treating Cluster Headache

Emgality Receives First FDA Approval for Treating Cluster Headache

Latest Migraine News TUESDAY, June 4, 2019 (HealthDay News) — The U.S. Food and Drug Administration granted Emgality (galcanezumab-gnlm) solution the first approval for treating episodic cluster headache, the agency announced yesterday. Previously approved for preventive treatment of migraine in adults, Emgality is administered through patient self-injection. The recommended dosage of Emgality for treatment of […]

Posted by
FDA Approves First Drug to Help Tame Cluster Headaches

FDA Approves First Drug to Help Tame Cluster Headaches

Latest Migraine News WEDNESDAY, June 5, 2019 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that’s the first to cut the frequency of cluster headaches. Episodic cluster headaches are “an extremely painful and often debilitating condition,” the FDA’s Dr. Eric Bastings noted in an […]

Posted by
FDA OKs Wearable Device for Migraine Pain

FDA OKs Wearable Device for Migraine Pain

By Megan BrooksWebMD Health News May 29, 2019 — The FDA has cleared a noninvasive device to relieve acute migraine pain. Latest Migraine News Nerivio Migra is a “first-in-category product,” according to Theranica, the company that makes it. It is worn on the upper arm and uses smartphone-controlled electronic pulses to relieve migraine pain. The […]

Posted by
Migraine Pain Linked to Raised Suicide Risk

Migraine Pain Linked to Raised Suicide Risk

Latest Migraine News WEDNESDAY, April 10, 2019 (HealthDay News) — People with migraine may be much more likely to attempt suicide than others, a new study suggests. It found that 1 in 12 adults with migraine had attempted suicide — and those with a history of sexual abuse or long-term exposure to domestic violence had […]